2007 Cannabinoids Clinical Trials Patients 
Otherside Farms
JANUARY 23, 2019
Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.
Greencamp
FEBRUARY 2, 2019
Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Cannabis as a palliative aid for HIV patients. What is HIV and how is it manifested? How classical pharmaceuticals fight HIV.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Weedistry
MARCH 7, 2019
Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings.
The Cannigma
AUGUST 26, 2021
This represents nearly double the level of support found in a 2007 survey (21%). The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions.
Canna Care Docs
DECEMBER 11, 2018
A study published in the journal, Chemistry & Biodiversity , noted “marked improvement” in the quality of sleep in patients with chronic pain problems. [5] “Cannabis And Pain: A Clinical Review” Cannabis And Cannabinoid Research 2 (1): 96-104. Here, too, cannabis has been shown to have a distinct effect.
Cannabis Law Report
JUNE 11, 2019
A modest award for the cost of Cesamet/Nabilone, the synthetic cannabinoid, was awarded in this case. Just because another case finds marihuana useful for one patient does not automatically infer that it is medically necessary for another plaintiff. A significant award for Nabilone, the synthetic cannabinoid, was allowed in this case.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.
Expert insights. Personalized for you.
72 
Let's personalize your content